Xavier Codony

1.6k total citations
18 papers, 1.2k citations indexed

About

Xavier Codony is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Xavier Codony has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Xavier Codony's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Neuropeptides and Animal Physiology (8 papers) and Receptor Mechanisms and Signaling (6 papers). Xavier Codony is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Neuropeptides and Animal Physiology (8 papers) and Receptor Mechanisms and Signaling (6 papers). Xavier Codony collaborates with scholars based in Spain, United Kingdom and France. Xavier Codony's co-authors include Xavier Guitart, Xavier Monroy, Helmut Buschmann, Jörg Holenz, David J. Heal, Ramon Mercè, Petrus J. Pauwels, José Miguel Vela, Sharon L. Smith and Daniel Zamanillo and has published in prestigious journals such as Pain, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Xavier Codony

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Codony Spain 14 785 621 289 192 173 18 1.2k
Charles H. Mitch United States 25 1.1k 1.5× 1.0k 1.7× 251 0.9× 172 0.9× 184 1.1× 61 1.7k
Csaba Tömböly Hungary 22 724 0.9× 736 1.2× 133 0.5× 195 1.0× 254 1.5× 62 1.2k
Jeannette M. Watson United Kingdom 22 1.1k 1.4× 950 1.5× 183 0.6× 213 1.1× 89 0.5× 49 1.7k
Hyacinth C. Akunne United States 24 925 1.2× 1.0k 1.6× 248 0.9× 84 0.4× 107 0.6× 49 1.5k
F. David Tingley United States 13 795 1.0× 407 0.7× 147 0.5× 209 1.1× 310 1.8× 19 1.4k
D. Bruce Vaupel United States 21 1.1k 1.3× 830 1.3× 136 0.5× 180 0.9× 252 1.5× 58 1.6k
Jean-Louis Péglion France 22 539 0.7× 596 1.0× 418 1.4× 93 0.5× 75 0.4× 38 1.4k
Geo Adam Switzerland 22 1.2k 1.5× 1.1k 1.8× 298 1.0× 82 0.4× 217 1.3× 47 1.7k
Karen Benwell United Kingdom 13 401 0.5× 493 0.8× 120 0.4× 180 0.9× 104 0.6× 16 909
Peter J. Lovell United Kingdom 16 564 0.7× 511 0.8× 493 1.7× 75 0.4× 86 0.5× 23 1.2k

Countries citing papers authored by Xavier Codony

Since Specialization
Citations

This map shows the geographic impact of Xavier Codony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Codony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Codony more than expected).

Fields of papers citing papers by Xavier Codony

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Codony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Codony. The network helps show where Xavier Codony may publish in the future.

Co-authorship network of co-authors of Xavier Codony

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Codony. A scholar is included among the top collaborators of Xavier Codony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Codony. Xavier Codony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fernández‐Pastor, Begoña, Mónica Garcı́a, Javier Burgueño, et al.. (2022). Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids. Acta Pharmaceutica Sinica B. 13(1). 82–99. 4 indexed citations
2.
Castany, Sílvia, Xavier Codony, Daniel Zamanillo, et al.. (2019). Repeated Sigma-1 Receptor Antagonist MR309 Administration Modulates Central Neuropathic Pain Development After Spinal Cord Injury in Mice. Frontiers in Pharmacology. 10. 222–222. 27 indexed citations
3.
Merlos, Manuel, Enrique Portillo‐Salido, Bertrand Aubel, et al.. (2018). Administration of a co-crystal of tramadol and celecoxib in a 1:1 molecular ratio produces synergistic antinociceptive effects in a postoperative pain model in rats. European Journal of Pharmacology. 833. 370–378. 26 indexed citations
4.
Puente, Beatriz de la, Clara Touriño, S.A. Bura, et al.. (2013). Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects. European Journal of Pharmacology. 711(1-3). 63–72. 78 indexed citations
5.
Slotten, Helge A., et al.. (2011). E-6801, a 5-HT 6 receptor agonist, improves recognition memory by combined modulation of cholinergic. 2 indexed citations
6.
Slotten, Helge A., et al.. (2010). E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat. Psychopharmacology. 213(2-3). 413–430. 89 indexed citations
7.
Codony, Xavier, Javier Burgueño, Marı́a J. Ramı́rez, & José Miguel Vela. (2010). 5-HT6 Receptor Signal Transduction. International review of neurobiology. 94. 89–110. 14 indexed citations
8.
Nadal, Xavier, Luz Romero, Sergio Ovalle, et al.. (2010). Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity. Pain. 149(3). 483–494. 80 indexed citations
9.
10.
Tasler, Stefan, Oliver Müller, Elena Cubero, et al.. (2007). Discovery of 5-HT6 receptor ligands based on virtual HTS. Bioorganic & Medicinal Chemistry Letters. 17(22). 6224–6229. 5 indexed citations
11.
Romero, Gonzalo, Pilar Pérez, Xavier Codony, et al.. (2006). Efficacy of selective 5‐HT6 receptor ligands determined by monitoring 5‐HT6 receptor‐mediated cAMP signaling pathways. British Journal of Pharmacology. 148(8). 1133–1143. 48 indexed citations
12.
Codony, Xavier, Gonzalo Romero, Jesús Giraldo, et al.. (2006). Chronic 5‐HT 6 receptor modulation by E‐6837 induces hypophagia and sustained weight loss in diet‐induced obese rats. British Journal of Pharmacology. 148(7). 973–983. 76 indexed citations
13.
Holenz, Jörg, Petrus J. Pauwels, José Luis Dı́az, et al.. (2006). Medicinal chemistry strategies to 5-HT6 receptor ligands as potential cognitive enhancers and antiobesity agents. Drug Discovery Today. 11(7-8). 283–299. 133 indexed citations
14.
Guitart, Xavier, Xavier Codony, & Xavier Monroy. (2004). Sigma receptors: biology and therapeutic potential. Psychopharmacology. 174(3). 301–19. 201 indexed citations
15.
Holenz, Jörg, Ramon Mercè, José Luis Dı́az, et al.. (2004). Medicinal Chemistry Driven Approaches Toward Novel and Selective Serotonin 5-HT6Receptor Ligands. Journal of Medicinal Chemistry. 48(6). 1781–1795. 78 indexed citations
16.
Langa, Francina, Xavier Codony, Victoria Tovar, et al.. (2003). Generation and phenotypic analysis of sigma receptor type I (σ1) knockout mice. European Journal of Neuroscience. 18(8). 2188–2196. 162 indexed citations
17.
Guitart, Xavier, M. Ballarín, Xavier Codony, et al.. (1999). E-5842. Drugs of the Future. 24(4). 386–386. 7 indexed citations
18.
Guitart, Xavier, et al.. (1998). E‐5842: A New Potent and Preferential Sigma Ligand. Preclinical Pharmacological Profile. CNS Drug Reviews. 4(3). 201–224. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026